“Hemp for Human Rights” Company Aims to Make CBG More Accessible

Goodekind, a woman and minority-owned social enterprise that focuses on creating organically grown and consciously sourced hemp products, has released an affordable CBG topical and CBG crumble. Goodekind donates an eighth of their profits to human rights initiatives in the U.S.

Annabigerol, commonly known as CBG, is one of the most powerful cannabinoids because of its anti-inflammatory, anti-anxiety, and analgesic properties. The raw version of CBG is the precursor to the more commonly known cannabinoids THC and CBD. CBG’s costly price and rarity have made it known as the “Rolls Royce of cannabinoids” according to Forbes.

Goodekind’s CBG topical contains 300 mg of CBG and is designed to help with sore muscles, joint pain, and dry skin. CBG is relatively new to market and largely inaccessible to the mainstream public. Goodekind aims to change this by providing their CBG topical at $35 for a 2 oz jar. Goodekind’s CBG crumble is available for $40/gram and offers an effect comparable to THC, a convenience for those who live in states that have yet to legalize cannabis.

“CBG has a lot of benefits and we believe it to be the next big cannabinoid to hit the market. We are excited to be offering CBG products at an accessible price across the U.S. at a time when finding CBG can be a challenge,” Flip Croft-Caderao, co-founder of Goodekind said. “While our customers love our CBD products, we believe that the fondness of our CBG topical and CBG crumble will be even stronger.”

About Goodekind

Goodekind is a family-owned social enterprise focused on creating organically grown, consciously sourced hemp products. Goodekind offers CBD hemp flower, concentrates, vapes and tinctures and a CBG topical and crumble. One eighth of Goodekind’s profits fund human rights organizations serving the U.S. Goodekind is committed to sourcing completely from BIPOC or women owned farms and manufacturers by 2022. For more info, visit www.goodekind.com

Global Cannabis Times Staff

Global Cannabis Times is a joint venture of SmartWork Media, Zuber Lawler and Global Go. Drop us a line at editor@gctmag.com.

Share
Published by
Global Cannabis Times Staff

Recent Posts

Ohio’s Move to Adult-Use Sales Could Be Record-Setting

Approval of adult-use sales expected to ignite rapid expansion in Ohio's cannabis market.

2 months ago

Cannabis Investor Focus Shifts to Retail

A Data-Based Analysis of Location Strategies That Are Starting to Pay Off

2 months ago

More Hot Air? President’s SOU Speech Fails to Impress Cannabis Rights Groups

Last Prisoner Project and American Cannabis Collective want more action, not more words.

2 months ago

The Global Cannabis Times Interview with Raj Grover, Part 2

High Tide, Inc. CEO’s Journey from an Entrepreneurial Family in Mumbai to Cannabis Industry Leader.

5 months ago

The Global Cannabis Times Interview with Raj Grover, Part 1

High Tide, Inc. CEO’s Journey from an Entrepreneurial Family in Mumbai to Cannabis Industry Leader.

5 months ago

Japan Legalizes Medical Cannabis Products, Tightens Drug Laws

New legislation paves the way for cannabis-based medicines while strengthening prohibitions against recreational use.

5 months ago

This website uses cookies.